Stocks of Option Care Health Inc. (NASDAQ:OPCH) traded higher last session on Wall Street, down -0.18% to $27.73.
According to the data, Option Care Health Inc. (NASDAQ:OPCH) has 8 analysts covering its stock. The consensus rating among analysts is ‘Buy’. As we calculate the median target price by taking the range between a high of $43.00 and a low of $35.00, we find $41.00. Given the previous closing price of $27.78, this indicates a potential upside of 47.59 percent. OPCH stock price is now -17.32% away from the 50-day moving average and -11.75% away from the 200-day moving average. The market capitalization of the company currently stands at $4.99B.
A total of 0 analysts have issued a hold rating and 8 have given it a buy rating. Brokers who have rated the stock have averaged $39.71 as their price target over the next twelve months.
In other news, Pate R Carter, Director bought 1,465 shares of the company’s stock on Aug 17. The stock was bought for $50,279 at an average price of $34.32. Upon completion of the transaction, the Director now directly owns 106,112 shares in the company, valued at $2.94 million. An SEC document containing details of the transaction can be found on the SEC’s website. On Aug 14, GC & Corporate Secretary Smyser Collin bought 2,500 shares of the business’s stock. A total of $86,725 was incurred on buying the stock at an average price of $34.69. This leaves the insider owning 2,500 shares of the company worth $69325.0. Insiders disposed of 15,507,700 shares of company stock worth roughly $430.03 million over the past 1 year. A total of 0.51% of the company’s stock is owned by insiders.
There have been several recent changes in the stakes of large investors in OPCH stock. A new stake in Option Care Health Inc. shares was purchased by TOMS CAPITAL INVESTMENT MANAGEMENT LP during the first quarter worth $121,774,000. THIRD POINT LLC invested $97,055,000 in shares of OPCH during the first quarter. In the first quarter, WELLINGTON MANAGEMENT GROUP LLP acquired a new stake in Option Care Health Inc. valued at approximately $69,291,000. ALYESKA INVESTMENT GROUP, L.P. acquired a new stake in OPCH for approximately $66,759,000. FARALLON CAPITAL MANAGEMENT LLC purchased a new stake in OPCH valued at around $57,322,000 in the second quarter. In total, there are 411 active investors with 97.86% ownership of the company’s stock.
Thursday’s opening bell rang with an opening price of $28.15 for Option Care Health Inc. (NASDAQ: OPCH). During the past 12 months, Option Care Health Inc. has had a low of $24.23 and a high of $35.87. As of last week, the company has a debt-to-equity ratio of 0.81, a current ratio of 1.79, and a quick ratio of 1.39. According to the stock market information, the enterprise value for the company is $5.67B, which is based on a 19.57 price-to-earnings ratio, a 0.97 price-to-earnings-growth ratio, and a beta of 1.20. The fifty day moving average price for OPCH is $33.40 and a two-hundred day moving average price translates $31.42 for the stock.
The latest earnings results from Option Care Health Inc. (NASDAQ: OPCH) was released for Sep, 2023. The net profit margin was 6.12% and return on equity was 18.54% for OPCH. The company reported revenue of $1.09 billion for the quarter, compared to $1.02 billion a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue rose 7.06 percent.
Option Care Health Inc.(OPCH) Company Profile
Option Care Health, Inc. offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including Crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders. It also offers treatments to manage the progression of neurological disorders, such as multiple sclerosis, duchenne muscular dystrophy, and others; infusion therapies for bleeding disorders; therapies that women need to survive and thrive through high-risk pregnancies; and other infusion therapies to treat various conditions, including pain management, chemotherapy, and respiratory medications, as well as nursing services. Option Care Health, Inc. is headquartered in Bannockburn, Illinois.
